Kessler Investment Group LLC Lowers Holdings in Petmed Express Inc (PETS)

Share on StockTwits

Kessler Investment Group LLC lowered its holdings in shares of Petmed Express Inc (NASDAQ:PETS) by 38.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,284 shares of the company’s stock after selling 808 shares during the quarter. Kessler Investment Group LLC’s holdings in Petmed Express were worth $30,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also added to or reduced their stakes in the business. First Hawaiian Bank bought a new position in Petmed Express during the fourth quarter valued at $193,000. North Star Investment Management Corp. lifted its position in Petmed Express by 48.7% during the fourth quarter. North Star Investment Management Corp. now owns 114,456 shares of the company’s stock valued at $2,662,000 after purchasing an additional 37,503 shares during the last quarter. Palo Capital Inc. bought a new position in Petmed Express during the third quarter valued at $237,000. Morgan Stanley lifted its position in Petmed Express by 110.1% during the third quarter. Morgan Stanley now owns 312,416 shares of the company’s stock valued at $10,313,000 after purchasing an additional 163,691 shares during the last quarter. Finally, Legal & General Group Plc lifted its position in Petmed Express by 8.9% during the third quarter. Legal & General Group Plc now owns 44,434 shares of the company’s stock valued at $1,490,000 after purchasing an additional 3,626 shares during the last quarter. Institutional investors and hedge funds own 95.04% of the company’s stock.

Several research firms have commented on PETS. ValuEngine upgraded shares of Petmed Express from a “strong sell” rating to a “sell” rating in a research report on Friday, October 26th. BidaskClub lowered shares of Petmed Express from a “sell” rating to a “strong sell” rating in a research report on Thursday, November 15th. Finally, TheStreet lowered shares of Petmed Express from a “b” rating to a “c+” rating in a research report on Thursday, November 29th. Three analysts have rated the stock with a sell rating and two have issued a hold rating to the company. The stock currently has a consensus rating of “Sell” and a consensus price target of $35.00.

Shares of PETS traded down $0.36 during midday trading on Friday, hitting $22.39. The stock had a trading volume of 20,047 shares, compared to its average volume of 586,929. Petmed Express Inc has a 1 year low of $21.85 and a 1 year high of $57.80. The company has a market cap of $502.79 million, a P/E ratio of 11.69 and a beta of 0.74.

Petmed Express (NASDAQ:PETS) last announced its earnings results on Monday, October 22nd. The company reported $0.52 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.50 by $0.02. Petmed Express had a net margin of 14.88% and a return on equity of 35.53%. The business had revenue of $71.40 million for the quarter, compared to the consensus estimate of $71.93 million. During the same quarter in the prior year, the firm posted $0.43 earnings per share. The business’s revenue for the quarter was up 7.0% on a year-over-year basis.

TRADEMARK VIOLATION WARNING: “Kessler Investment Group LLC Lowers Holdings in Petmed Express Inc (PETS)” was originally posted by Week Herald and is owned by of Week Herald. If you are viewing this story on another publication, it was stolen and republished in violation of U.S. & international trademark and copyright law. The correct version of this story can be viewed at https://weekherald.com/2019/01/11/kessler-investment-group-llc-lowers-holdings-in-petmed-express-inc-pets.html.

Petmed Express Profile

PetMed Express, Inc and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. It markets prescription and non-prescription pet medications, and other health products for dogs and cats directly to the consumers. The company offers non-prescription medications and supplies, including flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, such as heartworm preventative, flea and tick preventative, arthritis, thyroid, diabetes, pain, heart/blood pressure, and other specialty medications, as well as generic substitutes.

Featured Story: What is the S&P 500 Index?

Want to see what other hedge funds are holding PETS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Petmed Express Inc (NASDAQ:PETS).

Institutional Ownership by Quarter for Petmed Express (NASDAQ:PETS)

Receive News & Ratings for Petmed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Petmed Express and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply